Eric Marcotte

Eric Marcotte has extensive experience in the field of health research, particularly in the areas of epigenetics, regenerative medicine, and nanomedicine. Eric has held various leadership roles, including Associate Scientific Director and Associate Director at the Canadian Institutes of Health Research (CIHR), where they led initiatives such as the Canadian Epigenetics, Environment and Health Research Consortium (CEEHRC) and the Regenerative Medicine and Nanomedicine Initiative (RMNI). Additionally, Eric served as the Chair of the International Human Epigenome Consortium (IHEC), a global consortium focused on providing access to high-resolution reference human epigenome maps. Eric has also contributed to the academic community as an Associate Director at McGill University and a Sessional Lecturer at McMaster University. Prior to entering the field of health research, Eric worked as a Biotechnology Analyst at Galileo Global Equity Advisors Inc. Eric is currently an Associate Scientific Director and Associate Director at the University of Calgary.

Eric Marcotte's education history is as follows: From 1991 to 1998, they attended McMaster University, where they earned a Doctor of Philosophy (PhD) degree in Neuropharmacology. Following this, from 1998 to 2001, they enrolled at McGill University as an MRC Post-Doctoral Fellow at the Douglas Hospital Research Centre.